Lord, Abbett & Co
ISEE

Lord, Abbett & Co’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Lord, Abbett & Co’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-169,710
Closed -$4.13M – 599
2023
Q1 		$4.13M Buy
169,710
+6,377
+4% +$140K 0.01% 490
2022
Q4 		$3.5M Buy
+163,333
New +$3.49M 0.01% 525
2016
Q3 		– Sell
-46,672
Closed -$2.38M – 952
2016
Q2 		$2.38M Sell
46,672
-18,383
-28% -$913K 0.01% 822
2016
Q1 		$2.75M Sell
65,055
-390,777
-86% -$19.9M 0.01% 802
2015
Q4 		$35.8M Buy
455,832
+353,422
+345% +$20.4M 0.11% 298
2015
Q3 		$4.15M Buy
+102,410
New +$5.43M 0.01% 769
2015
Q2 		– Sell
-108,113
Closed -$5.03M – 1002
2015
Q1 		$5.03M Buy
+108,113
New +$5.61M 0.01% 742

Other funds holding ISEE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Lord, Abbett & Co's ISEE Position: Q2 2023 in Review

Lord, Abbett & Co sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2023, closing a stake of 169,710 shares — an estimated $4.13M sold.

Lord, Abbett & Co first reported a position in ISEE in Q1 2015 and held it in 7 quarters. The position peaked at $35.8M in Q4 2015. 256 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.

  • Lord, Abbett & Co reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Lord, Abbett & Co sold 169,710 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $4.13M.
  • Lord, Abbett & Co first reported a position in IVERIC bio, Inc. Common Stock in Q1 2015 and held it in 7 quarters.
  • Lord, Abbett & Co's IVERIC bio, Inc. Common Stock position peaked at $35.8M in Q4 2015.
  • 256 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.

Based on Lord, Abbett & Co's 13F filing for Q2 2023, filed 14 Aug 2023.